![A Randomized, Double-Blind, Placebo-Controlled Phase II Study of Hepatocyte Growth Factor in the Treatment of Critical Limb Ischemia: Molecular Therapy A Randomized, Double-Blind, Placebo-Controlled Phase II Study of Hepatocyte Growth Factor in the Treatment of Critical Limb Ischemia: Molecular Therapy](https://www.cell.com/cms/attachment/f7119006-e9eb-45cc-a48a-f2878fe07e4a/gr1.jpg)
A Randomized, Double-Blind, Placebo-Controlled Phase II Study of Hepatocyte Growth Factor in the Treatment of Critical Limb Ischemia: Molecular Therapy
![A 24‐Week, Phase IIa, Randomized, Double‐Blind, Placebo‐Controlled Study of Ziritaxestat in Early Diffuse Cutaneous Systemic Sclerosis - Khanna - 2023 - Arthritis & Rheumatology - Wiley Online Library A 24‐Week, Phase IIa, Randomized, Double‐Blind, Placebo‐Controlled Study of Ziritaxestat in Early Diffuse Cutaneous Systemic Sclerosis - Khanna - 2023 - Arthritis & Rheumatology - Wiley Online Library](https://acrjournals.onlinelibrary.wiley.com/cms/asset/42a9bbfa-0a1d-492b-a993-03d696724f84/art42477-toc-0001-m.jpg?trick=1696346236522)
A 24‐Week, Phase IIa, Randomized, Double‐Blind, Placebo‐Controlled Study of Ziritaxestat in Early Diffuse Cutaneous Systemic Sclerosis - Khanna - 2023 - Arthritis & Rheumatology - Wiley Online Library
![A Phase III, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study of 2 Dosing Regimens of Fostamatinib in Patients with Rheumatoid Arthritis with an Inadequate Response to a Tumor Necrosis Factor-α Antagonist | The A Phase III, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study of 2 Dosing Regimens of Fostamatinib in Patients with Rheumatoid Arthritis with an Inadequate Response to a Tumor Necrosis Factor-α Antagonist | The](https://www.jrheum.org/content/jrheum/41/11/2120/F1.large.jpg)
A Phase III, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study of 2 Dosing Regimens of Fostamatinib in Patients with Rheumatoid Arthritis with an Inadequate Response to a Tumor Necrosis Factor-α Antagonist | The
![Influenza Vaccination after Myocardial Infarction - a randomized, double- blind, placebo-controlled, multicenter trial | tctmd.com Influenza Vaccination after Myocardial Infarction - a randomized, double- blind, placebo-controlled, multicenter trial | tctmd.com](https://d14d5nk8lue86f.cloudfront.net/s3fs-public/2021-09/Frobert_IAMI.png)
Influenza Vaccination after Myocardial Infarction - a randomized, double- blind, placebo-controlled, multicenter trial | tctmd.com
![Blood Journal on X: "A randomized double-blind trial of 3 aspirin regimens to optimize antiplatelet therapy in essential thrombocythemia https://t.co/lJNxpqQqXK https://t.co/7OcnMKLAjT" / X Blood Journal on X: "A randomized double-blind trial of 3 aspirin regimens to optimize antiplatelet therapy in essential thrombocythemia https://t.co/lJNxpqQqXK https://t.co/7OcnMKLAjT" / X](https://pbs.twimg.com/media/EclA2eGXYAE9HOs.png:large)
Blood Journal on X: "A randomized double-blind trial of 3 aspirin regimens to optimize antiplatelet therapy in essential thrombocythemia https://t.co/lJNxpqQqXK https://t.co/7OcnMKLAjT" / X
![Design of the randomized, double-blind, controlled, cross-over study in... | Download Scientific Diagram Design of the randomized, double-blind, controlled, cross-over study in... | Download Scientific Diagram](https://www.researchgate.net/publication/237241329/figure/fig1/AS:299478704771073@1448412695171/Design-of-the-randomized-double-blind-controlled-cross-over-study-in-which-subjects.png)
Design of the randomized, double-blind, controlled, cross-over study in... | Download Scientific Diagram
![Study design. A randomized, double-blind, placebo-controlled, crossover... | Download Scientific Diagram Study design. A randomized, double-blind, placebo-controlled, crossover... | Download Scientific Diagram](https://www.researchgate.net/publication/24146123/figure/fig1/AS:310160045166596@1450959325482/Study-design-A-randomized-double-blind-placebo-controlled-crossover-study.png)
Study design. A randomized, double-blind, placebo-controlled, crossover... | Download Scientific Diagram
![A phase 1, randomized double-blind, placebo controlled trial to evaluate safety and efficacy of epigallocatechin-3-gallate and cognitive training in adults with Fragile X syndrome - ScienceDirect A phase 1, randomized double-blind, placebo controlled trial to evaluate safety and efficacy of epigallocatechin-3-gallate and cognitive training in adults with Fragile X syndrome - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0261561419300822-fx1.jpg)
A phase 1, randomized double-blind, placebo controlled trial to evaluate safety and efficacy of epigallocatechin-3-gallate and cognitive training in adults with Fragile X syndrome - ScienceDirect
![A randomized, double-blind, placebo-controlled trial of pramipexole augmentation in treatment-resistant major depressive disorder. A randomized, double-blind, placebo-controlled trial of pramipexole augmentation in treatment-resistant major depressive disorder.](https://dukespace.lib.duke.edu/dspace/bitstream/handle/10161/24821/Cusin_Perlis-2013_Double-blind%2C%20placebo-controlled%20trial%20of%20pramipexole%20augmentation%20in%20treatment-resistant%20major%20depressive%20disorder.pdf.jpg?sequence=4&isAllowed=y)
A randomized, double-blind, placebo-controlled trial of pramipexole augmentation in treatment-resistant major depressive disorder.
![A Prospective, Randomized, Double-Blind Study to Evaluate the Safety, Biodistribution, and Dosimetry of 68Ga-NODAGA-LM3 and 68Ga-DOTA-LM3 in Patients with Well-Differentiated Neuroendocrine Tumors | Journal of Nuclear Medicine A Prospective, Randomized, Double-Blind Study to Evaluate the Safety, Biodistribution, and Dosimetry of 68Ga-NODAGA-LM3 and 68Ga-DOTA-LM3 in Patients with Well-Differentiated Neuroendocrine Tumors | Journal of Nuclear Medicine](https://jnm.snmjournals.org/content/jnumed/62/10/1398/F1.large.jpg)
A Prospective, Randomized, Double-Blind Study to Evaluate the Safety, Biodistribution, and Dosimetry of 68Ga-NODAGA-LM3 and 68Ga-DOTA-LM3 in Patients with Well-Differentiated Neuroendocrine Tumors | Journal of Nuclear Medicine
![A randomized, double-blind, placebo-controlled, dose-escalating phase I trial to evaluate safety and immunogenicity of a plant-produced, bivalent, recombinant norovirus-like particle vaccine A randomized, double-blind, placebo-controlled, dose-escalating phase I trial to evaluate safety and immunogenicity of a plant-produced, bivalent, recombinant norovirus-like particle vaccine](https://biblio.ugent.be/publication/8769973/file/01GJFQRZDTV3DNZKM310ZA861F/thumbnail.png)
A randomized, double-blind, placebo-controlled, dose-escalating phase I trial to evaluate safety and immunogenicity of a plant-produced, bivalent, recombinant norovirus-like particle vaccine
![ELAMIPRETIDE IN PATIENTS WITH BARTH SYNDROME: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED CLINICAL TRIAL FOLLOWED BY 36-WEEK OPEN-LABEL EXTENSION | Journal of the American College of Cardiology ELAMIPRETIDE IN PATIENTS WITH BARTH SYNDROME: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED CLINICAL TRIAL FOLLOWED BY 36-WEEK OPEN-LABEL EXTENSION | Journal of the American College of Cardiology](https://www.jacc.org/cms/asset/f707f216-ce39-4329-bc3c-2f088569dc01/s0735-1097(20)31584-9.fp.png)
ELAMIPRETIDE IN PATIENTS WITH BARTH SYNDROME: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED CLINICAL TRIAL FOLLOWED BY 36-WEEK OPEN-LABEL EXTENSION | Journal of the American College of Cardiology
Randomized, double-blind, placebo-controlled clinical trial flow. The... | Download Scientific Diagram
![PDF] Randomized, double-blind, placebo-controlled study of oral lactobacilli to improve the vaginal flora of postmenopausal women. | Semantic Scholar PDF] Randomized, double-blind, placebo-controlled study of oral lactobacilli to improve the vaginal flora of postmenopausal women. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/ab0eed333e048a6e9cca0ee625f68e638cf34166/2-Figure1-1.png)